New Federal IVF Drug Discounts May Benefit IFI Patients
Policy Update: IVF Costs Could Drop in 2026
President Trump announced a new initiative on October 16, 2025, aimed at making fertility care more affordable. Key highlights include:
-
Medication Discounts: IVF drugs like Gonal-f, Ovidrel, and Cetrotide will be offered at reduced prices through TrumpRX, a government-backed platform launching in 2026.
-
Employer Benefit Guidance: Employers will be encouraged to offer infertility coverage, though no federal subsidies or mandates are planned.
-
FDA Acceleration: Pergoveris will be fast-tracked for approval to expand treatment options.
Impact for IFI Patients
-
Considering IVF? Lower drug prices could reduce your total treatment cost. IFI’s team is ready to help you plan.
-
Currently in Treatment? Your medication plan remains unchanged for now. IFI will help you assess future eligibility for discounts.
-
Employer Insurance? More companies may offer fertility benefits. IFI can help you review your coverage.
-
All Patients: These changes may improve access to care. IFI will keep you informed as updates roll out.
What You Should Know
-
The TrumpRX program is expected to launch in early 2026.
-
Discounts apply only to specific EMD Serono medications.
-
IFI will continue to provide transparent updates and support.
Start Now—Don’t Delay Care
While national efforts are underway, the timeline and impact remain uncertain. For many patients, waiting could mean missing their best chance to conceive.
IFI is committed to helping you act now with clarity and confidence. Schedule a consultation with our team today to explore your options.
For more details, see: Reuters — White House set to announce proposal seeking to make IVF more accessible or visit The Prelude Network® website.